BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 25918388)

  • 21. Epidermal growth factor receptor signaling in hepatocellular carcinoma: inflammatory activation and a new intracellular regulatory mechanism.
    Berasain C; Nicou A; Garcia-Irigoyen O; Latasa MU; Urtasun R; Elizalde M; Salis F; Perugorría MJ; Prieto J; Recio JA; Corrales FJ; Avila MA
    Dig Dis; 2012; 30(5):524-31. PubMed ID: 23108309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Upregulation of Nox4 promotes angiotensin II-induced epidermal growth factor receptor activation and subsequent cardiac hypertrophy by increasing ADAM17 expression.
    Zeng SY; Chen X; Chen SR; Li Q; Wang YH; Zou J; Cao WW; Luo JN; Gao H; Liu PQ
    Can J Cardiol; 2013 Oct; 29(10):1310-9. PubMed ID: 23850346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A disintegrin and metalloprotease 17 promotes microglial cell survival via epidermal growth factor receptor signalling following spinal cord injury.
    Wei Z; Yu D; Bi Y; Cao Y
    Mol Med Rep; 2015 Jul; 12(1):63-70. PubMed ID: 25738567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of the function of ADAM17 in iRhom2 curly-bare and tylosis with esophageal cancer mutant mice.
    Rabinowitsch AI; Maretzky T; Weskamp G; Haxaire C; Tueshaus J; Lichtenthaler SF; Monette S; Blobel CP
    J Cell Sci; 2023 Jul; 136(13):. PubMed ID: 37282854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TGFβ induces proHB-EGF shedding and EGFR transactivation through ADAM activation in gastric cancer cells.
    Ebi M; Kataoka H; Shimura T; Kubota E; Hirata Y; Mizushima T; Mizoshita T; Tanaka M; Mabuchi M; Tsukamoto H; Tanida S; Kamiya T; Higashiyama S; Joh T
    Biochem Biophys Res Commun; 2010 Nov; 402(3):449-54. PubMed ID: 20934403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mammary ductal morphogenesis requires paracrine activation of stromal EGFR via ADAM17-dependent shedding of epithelial amphiregulin.
    Sternlicht MD; Sunnarborg SW; Kouros-Mehr H; Yu Y; Lee DC; Werb Z
    Development; 2005 Sep; 132(17):3923-33. PubMed ID: 16079154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ADAMs 10 and 17 represent differentially regulated components of a general shedding machinery for membrane proteins such as transforming growth factor alpha, L-selectin, and tumor necrosis factor alpha.
    Le Gall SM; Bobé P; Reiss K; Horiuchi K; Niu XD; Lundell D; Gibb DR; Conrad D; Saftig P; Blobel CP
    Mol Biol Cell; 2009 Mar; 20(6):1785-94. PubMed ID: 19158376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands.
    Sahin U; Weskamp G; Kelly K; Zhou HM; Higashiyama S; Peschon J; Hartmann D; Saftig P; Blobel CP
    J Cell Biol; 2004 Mar; 164(5):769-79. PubMed ID: 14993236
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A disintegrin and metalloproteinase 17 (ADAM17) mediates epidermal growth factor receptor transactivation by angiotensin II on hepatic stellate cells.
    Oikawa H; Maesawa C; Tatemichi Y; Nishinari Y; Nishiya M; Mizugai H; Ikeda A; Oikawa K; Takikawa Y; Masuda T
    Life Sci; 2014 Mar; 97(2):137-44. PubMed ID: 24412389
    [TBL] [Abstract][Full Text] [Related]  

  • 30. iRhom2 regulates CSF1R cell surface expression and non-steady state myelopoiesis in mice.
    Qing X; Rogers L; Mortha A; Lavin Y; Redecha P; Issuree PD; Maretzky T; Merad M; McIlwain D; Mak TW; Overall CM; Blobel CP; Salmon JE
    Eur J Immunol; 2016 Dec; 46(12):2737-2748. PubMed ID: 27601030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TWEAK transactivation of the epidermal growth factor receptor mediates renal inflammation.
    Rayego-Mateos S; Morgado-Pascual JL; Sanz AB; Ramos AM; Eguchi S; Batlle D; Pato J; Keri G; Egido J; Ortiz A; Ruiz-Ortega M
    J Pathol; 2013 Dec; 231(4):480-94. PubMed ID: 24037740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cryo-EM reveals that iRhom2 restrains ADAM17 protease activity to control the release of growth factor and inflammatory signals.
    Lu F; Zhao H; Dai Y; Wang Y; Lee CH; Freeman M
    Mol Cell; 2024 Jun; 84(11):2152-2165.e5. PubMed ID: 38781971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Status update on iRhom and ADAM17: It's still complicated.
    Düsterhöft S; Babendreyer A; Giese AA; Flasshove C; Ludwig A
    Biochim Biophys Acta Mol Cell Res; 2019 Oct; 1866(10):1567-1583. PubMed ID: 31330158
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The iRhom homology domain is indispensable for ADAM17-mediated TNFα and EGF receptor ligand release.
    Düsterhöft S; Kahveci-Türköz S; Wozniak J; Seifert A; Kasparek P; Ohm H; Liu S; Kopkanova J; Lokau J; Garbers C; Preisinger C; Sedlacek R; Freeman M; Ludwig A
    Cell Mol Life Sci; 2021 Jun; 78(11):5015-5040. PubMed ID: 33950315
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of A disintegrin and metalloproteinase (ADAM) family sheddases ADAM10 and ADAM17: The emerging role of tetraspanins and rhomboids.
    Matthews AL; Noy PJ; Reyat JS; Tomlinson MG
    Platelets; 2017 Jun; 28(4):333-341. PubMed ID: 27256961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ADAM17 targets MMP-2 and MMP-9 via EGFR-MEK-ERK pathway activation to promote prostate cancer cell invasion.
    Xiao LJ; Lin P; Lin F; Liu X; Qin W; Zou HF; Guo L; Liu W; Wang SJ; Yu XG
    Int J Oncol; 2012 May; 40(5):1714-24. PubMed ID: 22200661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ADAM17 regulates epidermal growth factor receptor expression through the activation of Notch1 in non-small cell lung cancer.
    Baumgart A; Seidl S; Vlachou P; Michel L; Mitova N; Schatz N; Specht K; Koch I; Schuster T; Grundler R; Kremer M; Fend F; Siveke JT; Peschel C; Duyster J; Dechow T
    Cancer Res; 2010 Jul; 70(13):5368-78. PubMed ID: 20551051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. iRHOM2 is a critical pathogenic mediator of inflammatory arthritis.
    Issuree PD; Maretzky T; McIlwain DR; Monette S; Qing X; Lang PA; Swendeman SL; Park-Min KH; Binder N; Kalliolias GD; Yarilina A; Horiuchi K; Ivashkiv LB; Mak TW; Salmon JE; Blobel CP
    J Clin Invest; 2013 Feb; 123(2):928-32. PubMed ID: 23348744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FRMD8 promotes inflammatory and growth factor signalling by stabilising the iRhom/ADAM17 sheddase complex.
    Künzel U; Grieve AG; Meng Y; Sieber B; Cowley SA; Freeman M
    Elife; 2018 Jun; 7():. PubMed ID: 29897336
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The pseudoprotease iRhom1 controls ectodomain shedding of membrane proteins in the nervous system.
    Tüshaus J; Müller SA; Shrouder J; Arends M; Simons M; Plesnila N; Blobel CP; Lichtenthaler SF
    FASEB J; 2021 Nov; 35(11):e21962. PubMed ID: 34613632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.